(Q45419954)

English

Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Darren S Miller

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Michael Halpern

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Ieva Kotlarski

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Allison R Jilbert

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

8 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

348

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

297-308

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Fc gamma receptors and cross-presentation in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Kinetics of the immune response during HBV and HCV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Translation of immunological knowledge into better treatments of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Global epidemiology of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Dendritic cells acquire antigens from live cells for cross-presentation to CTL.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

A duck hepatitis B virus strain with a knockout mutation in the putative X ORF shows similar infectivity and in vivo growth characteristics to wild-type virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Protective immunisation against hepatitis B with an internal antigen of the virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Significance of maternal and infant serum antibodies to hepatitis B core antigen in hepatitis B virus infection of infancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Sequence comparison of an Australian duck hepatitis B virus strain with other avian hepadnaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Immunoglobulin- and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Clinical trial results and treatment resistance with lamivudine in hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.032

7 January 2021

Identifiers

10.1016/J.VIROL.2005.12.032

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45419954&oldid=2076899024"